Literature DB >> 30633411

Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.

Jason W Chan1, Iwei Yeh2, Ivan H El-Sayed3, Alain P Algazi4, Christine M Glastonbury5, Patrick K Ha3, Sue S Yom1, Annemieke van Zante6.   

Abstract

BACKGROUND: Head and neck squamous cell carcinoma of unknown primary site (HNSCCUP) is a diagnostic challenge. Identification of an ultraviolet (UV) light-related DNA damage signature using next-generation sequencing (NGS) can classify the primary site of origin as cutaneous.
METHODS: A 62-year-old male was seen with 2 months of left neck swelling. He was a lifetime nonsmoker but had a history of cutaneous squamous cell carcinoma (SCC) of the left helix. He was also found to have left hilar adenopathy. He had a p16-negative HNSCCUP on fine needle aspiration (FNA) biopsy of the left neck.
RESULTS: NGS of the FNA specimen revealed a high number of somatic mutations that were mostly C to T transitions, indicating a UV mutation signature and confirming the diagnosis of cutaneous SCC.
CONCLUSIONS: Identification of a UV DNA damage signature with NGS distinguishes HNSCCUP of cutaneous vs mucosal or other squamous cell carcinoma origin.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cutaneous tumor mutation burden; next-generation sequencing; skin cancer; ultraviolet light-related DNA damage signature; unknown primary squamous cell carcinoma of head and neck

Year:  2019        PMID: 30633411     DOI: 10.1002/hed.25613

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

Review 1.  Critical Changes in the Staging of Head and Neck Cancer.

Authors:  Christine M Glastonbury
Journal:  Radiol Imaging Cancer       Date:  2020-01-31

2.  Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas.

Authors:  May P Chan; Komal R Plouffe; Chia-Jen Liu; Nallasivam Palanisamy; Shannon Carskadon; Lili Zhao; Rosalynn M Nazarian; Alison B Durham; Timothy M Johnson; Aleodor A Andea; Rajiv M Patel; Lori Lowe; Douglas R Fullen; Noah A Brown; Scott A Tomlins; Aaron M Udager; Paul W Harms
Journal:  Mod Pathol       Date:  2019-12-19       Impact factor: 7.842

Review 3.  Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies.

Authors:  Yumi Kambayashi; Taku Fujimura; Takanori Hidaka; Setsuya Aiba
Journal:  Front Med (Lausanne)       Date:  2019-07-31

Review 4.  Updates in the management of unknown primary of the head and neck.

Authors:  Sandhya Kalavacherla; Parag Sanghvi; Grace Y Lin; Theresa Guo
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

5.  High Rates of Ultraviolet-Signature Mutations in Squamous Cell Carcinomas of the Parotid Gland and Prognostic Implications.

Authors:  Shira Fishbach; George Steinhardt; Chao Jie Zhen; Rutika Puranik; Jeremy P Segal; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2021-06-23

Review 6.  Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era.

Authors:  Francisco J Civantos; Jan B Vermorken; Jatin P Shah; Alessandra Rinaldo; Carlos Suárez; Luiz P Kowalski; Juan P Rodrigo; Kerry Olsen; Primoz Strojan; Antti A Mäkitie; Robert P Takes; Remco de Bree; June Corry; Vinidh Paleri; Ashok R Shaha; Dana M Hartl; William Mendenhall; Cesare Piazza; Michael Hinni; K Thomas Robbins; Ng Wai Tong; Alvaro Sanabria; Andres Coca-Pelaz; Johannes A Langendijk; Juan Hernandez-Prera; Alfio Ferlito
Journal:  Front Oncol       Date:  2020-11-10       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.